在pamidronate后改善骨质不完善的儿童的骨质特性:一个骨活检研究
Delphine Farlay1, Mathilde Cornier1, Sébastien Rizzo1
1INSERM UMR 1033, Univ Lyon, Université Claude Bernard Lyon 1, F-69008 Lyon, France.
JBMR plus
|January 17, 2025
概括
帕米德罗纳特 (PAM) 治疗患有骨质不完善 (OI) 或脆骨疾病的儿童,改善了骨质质量,成熟和纳米机械性质,表明抗骨折益处.
科学领域:
- 整形外科 整形外科 整形外科
- 生物材料科学 生物材料科学
- 儿科内分泌学 儿科内分泌学
背景情况:
- 骨质变生不完美 (OI) 或脆骨疾病涉及骨矿化增加,但其对抗吸收治疗的反应尚不清楚.
- 与对照组相比,未经处理的OI表现出骨密度降低 (皮层和无骨稀疏) .
研究的目的:
- 评估帕米德罗纳酸 (PAM) 对患有OI的儿童骨基质特征的影响.
- 为了比较静脉注射PAM治疗2年之前和之后的骨活检.
主要方法:
- 58名患有不同类型OI的儿童接受了2年的静脉PAM.
- 在治疗前的57名患者和治疗后的35名患者身上进行了转骨活检.
主要成果:
- PAM显著降低了骨重塑活动.
- 皮层厚度增加,有机和矿物质矩阵的成熟度得到改善.
- 尽管骨矿化进一步增加,但纳米机械性能得到了增强.
结论:
- 在OI患者中,帕米德罗纳酸 (PAM) 治疗增加了骨质量,并增强了骨基质成熟.
- 胺改善了原和矿物质晶体的成熟,有助于其在OI中的抗破裂功效.
相关概念视频
Bone Disorders
3.4K
Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
3.4K
Bone Remodeling
38.1K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.1K
Fractures: Bone Repair
2.9K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
2.9K
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Bone Structure
47.9K
Within the skeletal system, the structure of a bone, or osseous tissue, can be exemplified in a long bone, like the femur, where there are two types of osseous tissue: cortical and cancellous.
47.9K


